471. Safety and Efficacy of Oral and/or Intravenous Tedizolid Phosphate (TZD) in Adolescents with Acute Bacterial Skin and Skin Structure Tissue Infections (ABSSSI)

BACKGROUND: Tedizolid phosphate has activity against gram-positive pathogens, including methicillin-resistant Staphylococcus aureus, and was approved for the treatment of ABSSSI in adults in 2014. This study compared the safety and efficacy of TZD with protocol-specified, active comparators for the...

Descripción completa

Detalles Bibliográficos
Autores principales: Bradley, John S, Antadze, Tinatin, Mitha, Ismail H, Ninov, Borislav, Tayob, Mohammed S, Broyde, Natasha, Butterton, Joan R, Chou, Margaret Z, De Anda, Carisa S, Kim, Jason Y, Sears, Pamela S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809993/
http://dx.doi.org/10.1093/ofid/ofz360.544

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809993/
http://dx.doi.org/10.1093/ofid/ofz360.544

Ejemplares similares